Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A multicenter open-label extension study to evaluate long-term safety and efficacy of QCZ484 in hyp... Read More
U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587320) titled 'Multimodal Fascial Plane Block for Postoperative Analgesia in Isolated CABG Surgery' on Feb.... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascimi... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with ... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy v... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2 arm parallel-group, double-blind, placebo-... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'Bepirovirsen Liver Biopsy study'. The following are the other relevant details related to the trial... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing BMS-986504 in Combination with Nab-paclitaxel an... Read More
U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587697) titled 'A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing BMS-986504 in Combination with Nab-paclitaxel an... Read More